| abstract |
Provided are methods of reducing body fat in a subject, comprising locally (e.g., topically) administering one or more compounds of the Formula (I): n nor a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, polymorph, tautomer, isotopically enriched derivative, or prodrug thereof, wherein X is —OR 1 , —SR 2 , or —NR 3 R 4 , and R 1 , R 2 , R 3 , and R 4 are as defined herein. |